Table 11.
Liquid crystals as a potential drug delivery system for systemic infections treatment.
| Formulation | Drug | Composition | Therapeutic target | Route of administration | References |
|---|---|---|---|---|---|
| Liquid crystal | Zidovudine | PPG-5-CETETH-20/oleic acid | Human immunodeficiency virus | Nasal | Carvalho et al., 2013 |
| Liquid crystal | Ciprofloxacin | Monomuls®90-018 | Escherichia coli | Vaginal | Pisano et al.,2019 |
| Precursor of liquid crystal | Fluconazole | PPG-5-CETETH-20/trans-resveratrol/sodium alginate | Candida albicans | Oral | Miyashiro et al., 2020 |
PPG-5-CETETH-20: Procetyl®AWS.